XML 106 R68.htm IDEA: XBRL DOCUMENT v3.8.0.1
Earnings per Share (Details) - USD ($)
shares in Millions, $ in Millions
3 Months Ended
Mar. 31, 2018
Mar. 31, 2017
Numerator:    
Net income attributable to Biogen Inc $ 1,172.9 $ 747.6
Weighted-average shares used in calculating:    
Weighted average number of common shares outstanding 211.4 215.6
Effect of dilutive securities:    
Dilutive potential common shares 0.3 0.3
Shares used in calculating diluted earnings per share 211.7 215.9
Stock options and employee stock purchase plan    
Effect of dilutive securities:    
Stock units 0.0 0.0
Time-vested restricted stock units    
Effect of dilutive securities:    
Stock units 0.2 0.2
Market stock units    
Effect of dilutive securities:    
Stock units 0.1 0.1
Performance stock units settled in stock    
Effect of dilutive securities:    
Stock units 0.0 0.0